Associations between diffusion and perfusion parameters, N-acetyl aspartate, and lactate in acute ischemic stroke

Stroke

Volumn 40, Issue 3, 2009, Pages 767-772

  Cvoro, Vera ^a   Wardlaw, Joanna M ^a,d   Marshall, Ian ^a   Armitage, Paul A ^a   Rivers, Carly S ^c   Bastin, Mark E ^a   Carpenter, Trevor K ^a   Wartolowska, Karolina ^b   Farrall, Andrew J ^a   Dennis, Martin S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

ADC; CSI; DWI; Lactate; Metabolites; N acetyl aspartate; PWI; Spectroscopy; Stroke

Indexed keywords

LACTIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ACUTE DISEASE; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; IMAGING SYSTEM; METABOLITE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; BRAIN CIRCULATION; CELL DEATH; HUMAN; IMAGE PROCESSING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

ACUTE DISEASE; ASPARTIC ACID; BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LACTIC ACID; LINEAR MODELS; PROSPECTIVE STUDIES; STROKE;

EID: 62449200327     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.525626     Document Type: Article

References (39)

1. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Pierre Gobin Y, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/ perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462-469.
2. Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke. A systematic review. Stroke. 2006;37:1334-1339.
3. Monsein LH, Mathews VP, Barker PB, Pardo CA, Blackband SJ, Whitlow WD, Wong DF, Bryan RN. Irreversible regional cerebral ischemia: serial MR imaging and proton MR spectroscopy in a non-human primate model. Am J Neuroradiol. 2008;14:963-970.
4. Demougeot C, Marie C, Giroud M, Beley A. N-acetylaspartate: a literature review of animal research on brain ischemia. J Neurochem. 2004;90:783.
5. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatrie disorders. Prog Neurobiol. 1995;46:540.
6. Sager TN, Hansen AJ, Laursen H. Correlation between N-acetylaspartate levels and histopathologic changes in cortical infarcts of mice after middle cerebral artery occlusion. J Cereb Bl Flow Metab. 2000;20: 780-788.
7. Sager TN, Laursen H, Hansen AJ. Changes in N-aeetyl-aspartate content during focal and global brain ischemia of the rat. J Cereb Bl Flow Metab. 1995;15:639-646.
8. Rivers CS, Wardlaw JM. What has diffusion imaging in animals told us about diffusion imaging in patients with ischaemic stroke? Cerebrovasc Dis. 2005;19:328-336.
9. Parsons MW, Li T, Barber PA, Yang Q, Darby DG, Desmond PM, Gerraty, Tress BM RP, Davis SM. Combined IH MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology. 2000;55:498-505.
10. Liu Y-J, Chen C-Y, Chung H-W, Huang I-J, Lee C-S, Chin S-C, Liou M. Neuronal damage after ischemic injury in the middle cerebral arterial territory: deep watershed versus territorial infarction at MR perfusion and spectroscopic imaging. Radiology. 2003;229:366-374.
11. Nicoli F, Lefur Y, Denis B, Ranjeva JP, Confort-Gouny S, Cozzone PJ. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke. A brain proton magnetic resonance spectroscopic imaging study. Stroke. 2003;34:e82-e88.
12. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28.
13. Stengel A, Neumann-Haefelin T, Singer OC, Neumann-Haefelin C, Zanella FE, Lanfermann H, Pilatus U. Multiple spin-echo spectroscopic imaging for rapid quantitative assessment of N-acetylaspartate and lactate in acute stroke. Magn Reson Med. 2004;52:228-238.
14. Walker PM, Ben Salem D, Lalande A, Giroud M, Brunotte F. Time course of NAA T2 and ADC(w) in ischaemic stroke patients: IH MRS imaging and diffusion-weighted MRI. J Neurol Sci. 2004;220:23-28.
15. Labelle M, Khiat A, Durocher A, Boulanger Y. Comparison of metabolite levels and water diffusion between cortical and subcortical strokes as monitored by MRI and MRS. Invest Radiol. 2001;36:155-163.
16. Rumpel H, Khoo JB, Chang HM, Lim WE, Chen C, Wong MC, Tan KP. Correlation of the apparent diffusion coefficient and the creatine level in early ischemic stroke: a comparison of different patterns by magnetic resonance. J Magn Reson Imaging. 2001;13:335-343.
17. Rivers CS, Wardlaw JM, Armitage P, Bastin ME, Carpenter TK, Cvoro V, Hand PJ, Dennis MS. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke? Stroke. 2006;37: 98-104.
18. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med. 1996;36:726-736.
19. Carpenter T, Armitage PA, Bastin ME, Wardlaw JM. DSC Perfusion MRI - Quantification and reduction of systematic errors arising in areas of reduced cerebral blood flow. Magn Reson Med. 2006;55:1342-1349.
20. 1H magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in Signal Processing III. Oxford: Clarendon Press 1994: 175-95.
21. Vanhamme L, van den BA, Van HS. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129:35-43.
22. van den Boogaart A, De Beer R, Van Hecke A, Van Huffel P, GraveronDemilly S, van Ormondt D MRUI: a graphical user interface for accurate routine MRS data analysis. Proc ESMRMB 13th Annual Meeting, Prague 1996;318.
23. Guadagno JV, Warburton EA, Jones PS, Fryer TD, Day DJ, Gillard JH, Carpenter TA, Aigbirhio FI, Price CJ, Baron JC. The diffusion-weighted lesion in acute stroke: heterogeneous patterns of flow/metabolism uncoupling as assessed by quantitative positron emission tomography. Cerebrovasc Dis. 2005; 19:239-246.
24. Davis SM, Donnan GA. Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation. Stroke. 2005; 36:1106-1107.
25. Na DG, Thijs VN, Albers GW, Moseley ME, Marks MP. Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. Am J Neuroradiol. 2004;25:1331-1336.
26. Muñoz Maniega S, Cvoro, Armitage PA, Bastin ME, Wardlaw JM. Choline and creatine are not reliable denominators for calculating metabolite ratios in acute ischaemic stroke. Stroke. In press. DOI: 10.1161/STROKEAHA.107. 507060.
27. Gideon P, Sperling B, Arlien-Soborg P, Olsen TS, Henriksen O. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke. 1994;25:967-973.
28. Graham GD, Kalvach P, Blamire AM, Brass LM, Fayad PB, Prichard JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke. 1995;26:225-229.
29. Wardlaw JM, Marshall I, Wild J, Dennis MS, Cannon J, Lewis SC. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: Relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke. 1998;29:1618-1624.
30. Barker PB, Gillard JH, van Zijl PCM, Soher BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology. 1994; 192:723-732.
31. Lanfermann H, Kugel H, Heindel W, Herholz K, Heiss W-D, Lackner K. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology. 1995;196:203-210.
32. Lemesle M, Walker P, Guy F, D'Athis P, Billiar T, Giroud M, Demougeot C, Lalande A, Baudouin N, Martin D, Brunotte F. Multivariate analysis predicts clinical outcome 30 days after middle cerebral artery infarction. Acta Neurol Scand. 2000;102:11-17.
33. Pereira AC, Saunders DE, Doyle VL, Bland JM, Howe FA, Griffiths JR. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke. 1999;30:1577-1582.
34. Sijens PE, Den HT, deLeeuw FE, de Groot JC, Achten E, Heijboer RJ, Hofman A, Breteler MM, Oudkerk M. MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people. Eur Radiol. 2001;11:1495-1501.
35. Saunders DE, Howe FA, Van Der Boogaart A, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 1995;26:1007-1013.
36. Hand PJ, Wardlaw JM, Rivers CS, Armitage PA, Bastin ME, Lindley RI, Dennis MS. MR diffusion-weighted imaging and outcome prediction after ischemic stroke. Neurology. 2006;66:1159-1163.
37. Moseley ME, Cohen Y, Mintorovich J, Chileuitt L, Shimizu H, Kucharczyk J. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Mag ResMed. 1989;14:330-346.
38. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, Zeumer H, Rother J. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke. 2002;33:79-86.
39. Wu O, Christensen S, Hjort N, Dijkhuizen RM, Kucinski T, Fiehler J, Thomalla G, Rother J, Ostergaard L. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain. 2006;129:2384-2393.